Introduction to Cell Therapy Technologies
Cell therapy or cytotherapy is the transplantation of therapeutic cells into the body in order to repair the damaged tissues. The therapy is a widely new concept as the discovery of therapeutic properties of these cells is an ongoing process.
Cell therapy includes procedures such as blood transfusions, bone marrow transplants and organ transplants. The course of action of this therapy involves mainly two methods; one is the administration of stem cells which would reach the desired tissue and take place of the damaged cells, whereas, the other method involves administration of cells in order to repair the tissue. This therapy can be used for the treatment of a large number of diseases including cardiovascular diseases, cancer, nervous system related diseases and blood disorders.
Cell therapy technologies comprise of the technologies used to prepare cells for cell therapy as well as the devices used in the applications of cell therapy. The techniques of delivery of these specialized cells for cell therapy require certain medical devices ranging from injections to implants. In addition to these devices, other instruments and equipment used in the preparation of the therapeutic cells also form a part of cell therapy technologies.
Market Size and Forecast
The market for cell therapy technologies is anticipated to witness a significant growth owing to the rise in development of different forms of cell-based therapies. The production and handling of cells for cell therapy involve complicated procedures which require a number of techniques and instruments. The growth of the cell therapy technologies market is attributed to the increasing demand for these equipment and new technologies.
The cell therapy technologies market is anticipated to record a CAGR of around 15% and attain a significantly high market size over the forecast period i.e. 2019-2027. The market is segmented by cell type into human cells and animal cells, out of which, the human cells segment is anticipated to significantly boost the growth of cell therapy technologies market on account of increasing demand for human cells for cell therapy, leading to growth in the production of necessary equipment.
Get more information on this report: Download Sample PDF
Growth Drivers
The market for cell therapy technologies is driven by a rising demand for cell therapy for the treatment of various health disorders. The increased funding from government and private organizations to support clinical trials for cell therapy is another factor resulting in growth of the market. The increasing number of research institutions also results in an increasing demand for newer technologies and instruments.
Rising Incidences of Diseases
Diseases such as cancer, cardiovascular diseases and degenerative disorders have a high prevalence all around the world. According to American Cancer Society, 29% of childhood cancers are leukemia which may be treated by stem cell transplantation. This is leading to a higher demand for cell therapy, further supporting the growth of this market.
Growth in Cell-Based Research Industry
The advancements in cellular research has led to the increased usage of cell therapy technologies boosting the growth of the market. For instance, the new and advanced cell therapy manufacturing techniques and development of research facilities result in an expansion of the production and storage of cells, thereby leading to growth of the cytotherapy technologies market at a global level.
Restraints
High Cost of Research Activities
The successful research experiments conducted for the study of cell therapies are limited in number, resulting in limited usage of cell therapy technologies. In addition, the various research and development activities carried out by research institutions are highly expensive and time consuming which is anticipated to negatively affect the growth of cell therapy technologies market.
Market Segmentation
Our in-depth analysis of the cell therapy technologies market includes the following segments:
By Product Type
- Consumables
- Equipment
- Software
- Others
By Cell Type
- Human Cells
- Animal Cells
By Process Stages
- Cell Processing
- Handling
- Distribution
- Others
By Region
On the basis of regional analysis, the cell therapy technologies market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
The market in the North America region is anticipated to hold the leading share in cell therapy technologies market owing to the increasing development in the research facilities and research studies based on cell therapy. The growing number of research laboratories in the region is another factor leading to the expansion of the market. Furthermore, the market in Asia-Pacific region is estimated to experience the highest growth during the forecast period which can be attributed to the increased funding by government and private organizations for the research and development activities in healthcare industry.
The cell therapy technologies market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis
Top Featured Companies Dominating the Market
- Beckman Coulter
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Becton, Dickinson and Company
- GE Healthcare
- Merck KGaA
- Lonza
- Terumo BCT
- Thermo Fisher Scientific
- Novartis AG
- Sartorius AG
- Miltenyi Biotec
